Our Treatment Experience

Cord blood stem cells are playing a major role in transplant medicine, an innovative therapeutic approach to treating disease. ViaCord has helped more families utilize the healing power of their cord blood stem cells . To date, we have preserved the cord blood of more than 350,000 newborns. And we have released 325 stem cell collections for transplant or infusion to doctors and research - more than any other family bank.1,5  

Every cell counts.

Just as important as the depth of our experience is the proven quality of our stem cell collections. From collection to cryopreservation, our complete process is designed to maximize stem cell yield, which directly correlates with treatment success. The more stem cells that transplant doctors have to work with, the better the outcome for their patients. We've released 325 stem cell collections for use in treatment and clinical trials to date. See our Transplant & Infusion list for details.

An unmatched track record.

Nearly 90% of the medical treatments that utilized cord blood stem cells prepared by ViaCord have been successful - the highest rate shared by any family bank.9 We believe in the importance of publishing treatment success rates. After all, should you ever need to use your child’s stem cell collection, a healthy outcome is what matters most.

Dr. Mark Walters says...

"Our experience in umbilical cord blood transplantation has shown definitively that the single most important factor in ensuring a successful curative outcome is the number of cells that are infused at transplantation."

-  Mark Walters, MD 

Pediatric Hematologist/Oncologist, Children's Hospital Oakland, CA

Medical Director, ViaCord

Cord Blood In Action

When baby Brayden was born, Tami and her husband banked his cord blood with ViaCord and used it in a transplant to help treat their first son, Blase’s, leukemia. Watch a ViaCord mom share her story with Rosie Pope.